Covidien’s Pipeline Gains Unanimous Panel Endorsement For Large Aneurysms

FDA’s Neurological Devices Panel unanimously endorsed safety and efficacy data on Covidien’s Pipeline aneurysm embolization device March 18.

More from Archive

More from Medtech Insight